DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit MarginQuarterly Data
Annual Data
Quarterly Data
Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.
Eli Lilly & Co. (NYSE:LLY), DuPont Analysis (Q)
Johnson & Johnson (NYSE:JNJ), DuPont Analysis (Q)
AbbVie Inc. (NYSE:ABBV), DuPont Analysis (Q)
Merck & Co. Inc. (NYSE:MRK), DuPont Analysis (Q)
Thermo Fisher Scientific Inc. (NYSE:TMO), DuPont Analysis (Q)
Danaher Corp. (NYSE:DHR), DuPont Analysis (Q)
Amgen Inc. (NASDAQ:AMGN), DuPont Analysis (Q)
Pfizer Inc. (NYSE:PFE), DuPont Analysis (Q)
Bristol-Myers Squibb Co. (NYSE:BMY), DuPont Analysis (Q)
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), DuPont Analysis (Q)
Moderna Inc. (NASDAQ:MRNA), DuPont Analysis (Q)
Two-Component Disaggregation of ROE
Annual Data
Quarterly Data
Gilead Sciences Inc., decomposition of ROE (quarterly data)
ROE
=
ROA
×
Financial Leverage
Jun 30, 2024
5.77%
=
1.97%
×
2.93
Mar 31, 2024
2.77%
=
0.86%
×
3.21
Dec 31, 2023
24.81%
=
9.12%
×
2.72
Sep 30, 2023
26.33%
=
9.42%
×
2.80
Jun 30, 2023
25.92%
=
8.80%
×
2.95
Mar 31, 2023
26.59%
=
9.02%
×
2.95
Dec 31, 2022
21.62%
=
7.27%
×
2.97
Sep 30, 2022
15.82%
=
5.33%
×
2.97
Jun 30, 2022
20.44%
=
6.58%
×
3.11
Mar 31, 2022
22.66%
=
7.16%
×
3.17
Dec 31, 2021
29.55%
=
9.16%
×
3.23
Sep 30, 2021
34.44%
=
11.02%
×
3.13
Jun 30, 2021
26.20%
=
7.59%
×
3.45
Mar 31, 2021
1.59%
=
0.45%
×
3.56
Dec 31, 2020
0.68%
=
0.18%
×
3.76
Sep 30, 2020
7.27%
=
2.08%
×
3.49
Jun 30, 2020
-1.43%
=
-0.46%
×
3.10
Mar 31, 2020
22.49%
=
8.31%
×
2.71
Dec 31, 2019
23.91%
=
8.74%
×
2.74
Sep 30, 2019
—
=
—
×
2.87
Jun 30, 2019
—
=
—
×
2.79
Mar 31, 2019
—
=
—
×
2.86
Based on:
10-Q (reporting date: 2024-06-30) ,
10-Q (reporting date: 2024-03-31) ,
10-K (reporting date: 2023-12-31) ,
10-Q (reporting date: 2023-09-30) ,
10-Q (reporting date: 2023-06-30) ,
10-Q (reporting date: 2023-03-31) ,
10-K (reporting date: 2022-12-31) ,
10-Q (reporting date: 2022-09-30) ,
10-Q (reporting date: 2022-06-30) ,
10-Q (reporting date: 2022-03-31) ,
10-K (reporting date: 2021-12-31) ,
10-Q (reporting date: 2021-09-30) ,
10-Q (reporting date: 2021-06-30) ,
10-Q (reporting date: 2021-03-31) ,
10-K (reporting date: 2020-12-31) ,
10-Q (reporting date: 2020-09-30) ,
10-Q (reporting date: 2020-06-30) ,
10-Q (reporting date: 2020-03-31) ,
10-K (reporting date: 2019-12-31) ,
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) .
The primary reason for the increase in return on equity ratio (ROE) over Q2 2024 is the increase in profitability measured by return on assets ratio (ROA).
Three-Component Disaggregation of ROE
Annual Data
Quarterly Data
Gilead Sciences Inc., decomposition of ROE (quarterly data)
ROE
=
Net Profit Margin
×
Asset Turnover
×
Financial Leverage
Jun 30, 2024
5.77%
=
3.82%
×
0.52
×
2.93
Mar 31, 2024
2.77%
=
1.78%
×
0.48
×
3.21
Dec 31, 2023
24.81%
=
21.03%
×
0.43
×
2.72
Sep 30, 2023
26.33%
=
21.60%
×
0.44
×
2.80
Jun 30, 2023
25.92%
=
20.18%
×
0.44
×
2.95
Mar 31, 2023
26.59%
=
20.87%
×
0.43
×
2.95
Dec 31, 2022
21.62%
=
17.02%
×
0.43
×
2.97
Sep 30, 2022
15.82%
=
12.44%
×
0.43
×
2.97
Jun 30, 2022
20.44%
=
15.22%
×
0.43
×
3.11
Mar 31, 2022
22.66%
=
16.60%
×
0.43
×
3.17
Dec 31, 2021
29.55%
=
23.05%
×
0.40
×
3.23
Sep 30, 2021
34.44%
=
27.21%
×
0.41
×
3.13
Jun 30, 2021
26.20%
=
19.62%
×
0.39
×
3.45
Mar 31, 2021
1.59%
=
1.19%
×
0.37
×
3.56
Dec 31, 2020
0.68%
=
0.51%
×
0.36
×
3.76
Sep 30, 2020
7.27%
=
5.56%
×
0.37
×
3.49
Jun 30, 2020
-1.43%
=
-1.18%
×
0.39
×
3.10
Mar 31, 2020
22.49%
=
22.17%
×
0.37
×
2.71
Dec 31, 2019
23.91%
=
24.35%
×
0.36
×
2.74
Sep 30, 2019
—
=
—
×
—
×
2.87
Jun 30, 2019
—
=
—
×
—
×
2.79
Mar 31, 2019
—
=
—
×
—
×
2.86
Based on:
10-Q (reporting date: 2024-06-30) ,
10-Q (reporting date: 2024-03-31) ,
10-K (reporting date: 2023-12-31) ,
10-Q (reporting date: 2023-09-30) ,
10-Q (reporting date: 2023-06-30) ,
10-Q (reporting date: 2023-03-31) ,
10-K (reporting date: 2022-12-31) ,
10-Q (reporting date: 2022-09-30) ,
10-Q (reporting date: 2022-06-30) ,
10-Q (reporting date: 2022-03-31) ,
10-K (reporting date: 2021-12-31) ,
10-Q (reporting date: 2021-09-30) ,
10-Q (reporting date: 2021-06-30) ,
10-Q (reporting date: 2021-03-31) ,
10-K (reporting date: 2020-12-31) ,
10-Q (reporting date: 2020-09-30) ,
10-Q (reporting date: 2020-06-30) ,
10-Q (reporting date: 2020-03-31) ,
10-K (reporting date: 2019-12-31) ,
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) .
The primary reason for the increase in return on equity ratio (ROE) over Q2 2024 is the increase in profitability measured by net profit margin ratio.
Five-Component Disaggregation of ROE
Annual Data
Quarterly Data
Gilead Sciences Inc., decomposition of ROE (quarterly data)
ROE
=
Tax Burden
×
Interest Burden
×
EBIT Margin
×
Asset Turnover
×
Financial Leverage
Jun 30, 2024
5.77%
=
0.68
×
0.62
×
9.17%
×
0.52
×
2.93
Mar 31, 2024
2.77%
=
0.44
×
0.53
×
7.58%
×
0.48
×
3.21
Dec 31, 2023
24.81%
=
0.82
×
0.88
×
29.16%
×
0.43
×
2.72
Sep 30, 2023
26.33%
=
0.81
×
0.89
×
30.16%
×
0.44
×
2.80
Jun 30, 2023
25.92%
=
0.74
×
0.89
×
30.56%
×
0.44
×
2.95
Mar 31, 2023
26.59%
=
0.76
×
0.89
×
30.79%
×
0.43
×
2.95
Dec 31, 2022
21.62%
=
0.79
×
0.86
×
25.11%
×
0.43
×
2.97
Sep 30, 2022
15.82%
=
0.73
×
0.83
×
20.57%
×
0.43
×
2.97
Jun 30, 2022
20.44%
=
0.74
×
0.85
×
24.07%
×
0.43
×
3.11
Mar 31, 2022
22.66%
=
0.77
×
0.86
×
25.25%
×
0.43
×
3.17
Dec 31, 2021
29.55%
=
0.75
×
0.89
×
34.45%
×
0.40
×
3.23
Sep 30, 2021
34.44%
=
0.79
×
0.90
×
38.22%
×
0.41
×
3.13
Jun 30, 2021
26.20%
=
0.77
×
0.87
×
29.50%
×
0.39
×
3.45
Mar 31, 2021
1.59%
=
0.15
×
0.66
×
11.73%
×
0.37
×
3.56
Dec 31, 2020
0.68%
=
0.07
×
0.63
×
11.03%
×
0.36
×
3.76
Sep 30, 2020
7.27%
=
0.71
×
0.65
×
12.05%
×
0.37
×
3.49
Jun 30, 2020
-1.43%
=
—
×
-1.24
×
1.99%
×
0.39
×
3.10
Mar 31, 2020
22.49%
=
1.02
×
0.83
×
26.01%
×
0.37
×
2.71
Dec 31, 2019
23.91%
=
1.04
×
0.84
×
27.93%
×
0.36
×
2.74
Sep 30, 2019
—
=
—
×
—
×
—
×
—
×
2.87
Jun 30, 2019
—
=
—
×
—
×
—
×
—
×
2.79
Mar 31, 2019
—
=
—
×
—
×
—
×
—
×
2.86
Based on:
10-Q (reporting date: 2024-06-30) ,
10-Q (reporting date: 2024-03-31) ,
10-K (reporting date: 2023-12-31) ,
10-Q (reporting date: 2023-09-30) ,
10-Q (reporting date: 2023-06-30) ,
10-Q (reporting date: 2023-03-31) ,
10-K (reporting date: 2022-12-31) ,
10-Q (reporting date: 2022-09-30) ,
10-Q (reporting date: 2022-06-30) ,
10-Q (reporting date: 2022-03-31) ,
10-K (reporting date: 2021-12-31) ,
10-Q (reporting date: 2021-09-30) ,
10-Q (reporting date: 2021-06-30) ,
10-Q (reporting date: 2021-03-31) ,
10-K (reporting date: 2020-12-31) ,
10-Q (reporting date: 2020-09-30) ,
10-Q (reporting date: 2020-06-30) ,
10-Q (reporting date: 2020-03-31) ,
10-K (reporting date: 2019-12-31) ,
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) .
The primary reason for the increase in return on equity ratio (ROE) over Q2 2024 is the increase in effect of taxes measured by tax burden ratio.
Two-Component Disaggregation of ROA
Annual Data
Quarterly Data
Gilead Sciences Inc., decomposition of ROA (quarterly data)
ROA
=
Net Profit Margin
×
Asset Turnover
Jun 30, 2024
1.97%
=
3.82%
×
0.52
Mar 31, 2024
0.86%
=
1.78%
×
0.48
Dec 31, 2023
9.12%
=
21.03%
×
0.43
Sep 30, 2023
9.42%
=
21.60%
×
0.44
Jun 30, 2023
8.80%
=
20.18%
×
0.44
Mar 31, 2023
9.02%
=
20.87%
×
0.43
Dec 31, 2022
7.27%
=
17.02%
×
0.43
Sep 30, 2022
5.33%
=
12.44%
×
0.43
Jun 30, 2022
6.58%
=
15.22%
×
0.43
Mar 31, 2022
7.16%
=
16.60%
×
0.43
Dec 31, 2021
9.16%
=
23.05%
×
0.40
Sep 30, 2021
11.02%
=
27.21%
×
0.41
Jun 30, 2021
7.59%
=
19.62%
×
0.39
Mar 31, 2021
0.45%
=
1.19%
×
0.37
Dec 31, 2020
0.18%
=
0.51%
×
0.36
Sep 30, 2020
2.08%
=
5.56%
×
0.37
Jun 30, 2020
-0.46%
=
-1.18%
×
0.39
Mar 31, 2020
8.31%
=
22.17%
×
0.37
Dec 31, 2019
8.74%
=
24.35%
×
0.36
Sep 30, 2019
—
=
—
×
—
Jun 30, 2019
—
=
—
×
—
Mar 31, 2019
—
=
—
×
—
Based on:
10-Q (reporting date: 2024-06-30) ,
10-Q (reporting date: 2024-03-31) ,
10-K (reporting date: 2023-12-31) ,
10-Q (reporting date: 2023-09-30) ,
10-Q (reporting date: 2023-06-30) ,
10-Q (reporting date: 2023-03-31) ,
10-K (reporting date: 2022-12-31) ,
10-Q (reporting date: 2022-09-30) ,
10-Q (reporting date: 2022-06-30) ,
10-Q (reporting date: 2022-03-31) ,
10-K (reporting date: 2021-12-31) ,
10-Q (reporting date: 2021-09-30) ,
10-Q (reporting date: 2021-06-30) ,
10-Q (reporting date: 2021-03-31) ,
10-K (reporting date: 2020-12-31) ,
10-Q (reporting date: 2020-09-30) ,
10-Q (reporting date: 2020-06-30) ,
10-Q (reporting date: 2020-03-31) ,
10-K (reporting date: 2019-12-31) ,
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) .
The primary reason for the increase in return on assets ratio (ROA) over Q2 2024 is the increase in profitability measured by net profit margin ratio.
Four-Component Disaggregation of ROA
Annual Data
Quarterly Data
Gilead Sciences Inc., decomposition of ROA (quarterly data)
ROA
=
Tax Burden
×
Interest Burden
×
EBIT Margin
×
Asset Turnover
Jun 30, 2024
1.97%
=
0.68
×
0.62
×
9.17%
×
0.52
Mar 31, 2024
0.86%
=
0.44
×
0.53
×
7.58%
×
0.48
Dec 31, 2023
9.12%
=
0.82
×
0.88
×
29.16%
×
0.43
Sep 30, 2023
9.42%
=
0.81
×
0.89
×
30.16%
×
0.44
Jun 30, 2023
8.80%
=
0.74
×
0.89
×
30.56%
×
0.44
Mar 31, 2023
9.02%
=
0.76
×
0.89
×
30.79%
×
0.43
Dec 31, 2022
7.27%
=
0.79
×
0.86
×
25.11%
×
0.43
Sep 30, 2022
5.33%
=
0.73
×
0.83
×
20.57%
×
0.43
Jun 30, 2022
6.58%
=
0.74
×
0.85
×
24.07%
×
0.43
Mar 31, 2022
7.16%
=
0.77
×
0.86
×
25.25%
×
0.43
Dec 31, 2021
9.16%
=
0.75
×
0.89
×
34.45%
×
0.40
Sep 30, 2021
11.02%
=
0.79
×
0.90
×
38.22%
×
0.41
Jun 30, 2021
7.59%
=
0.77
×
0.87
×
29.50%
×
0.39
Mar 31, 2021
0.45%
=
0.15
×
0.66
×
11.73%
×
0.37
Dec 31, 2020
0.18%
=
0.07
×
0.63
×
11.03%
×
0.36
Sep 30, 2020
2.08%
=
0.71
×
0.65
×
12.05%
×
0.37
Jun 30, 2020
-0.46%
=
—
×
-1.24
×
1.99%
×
0.39
Mar 31, 2020
8.31%
=
1.02
×
0.83
×
26.01%
×
0.37
Dec 31, 2019
8.74%
=
1.04
×
0.84
×
27.93%
×
0.36
Sep 30, 2019
—
=
—
×
—
×
—
×
—
Jun 30, 2019
—
=
—
×
—
×
—
×
—
Mar 31, 2019
—
=
—
×
—
×
—
×
—
Based on:
10-Q (reporting date: 2024-06-30) ,
10-Q (reporting date: 2024-03-31) ,
10-K (reporting date: 2023-12-31) ,
10-Q (reporting date: 2023-09-30) ,
10-Q (reporting date: 2023-06-30) ,
10-Q (reporting date: 2023-03-31) ,
10-K (reporting date: 2022-12-31) ,
10-Q (reporting date: 2022-09-30) ,
10-Q (reporting date: 2022-06-30) ,
10-Q (reporting date: 2022-03-31) ,
10-K (reporting date: 2021-12-31) ,
10-Q (reporting date: 2021-09-30) ,
10-Q (reporting date: 2021-06-30) ,
10-Q (reporting date: 2021-03-31) ,
10-K (reporting date: 2020-12-31) ,
10-Q (reporting date: 2020-09-30) ,
10-Q (reporting date: 2020-06-30) ,
10-Q (reporting date: 2020-03-31) ,
10-K (reporting date: 2019-12-31) ,
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) .
The primary reason for the increase in return on assets ratio (ROA) over Q2 2024 is the increase in effect of taxes measured by tax burden ratio.
Disaggregation of Net Profit Margin
Annual Data
Quarterly Data
Gilead Sciences Inc., decomposition of net profit margin ratio (quarterly data)
Net Profit Margin
=
Tax Burden
×
Interest Burden
×
EBIT Margin
Jun 30, 2024
3.82%
=
0.68
×
0.62
×
9.17%
Mar 31, 2024
1.78%
=
0.44
×
0.53
×
7.58%
Dec 31, 2023
21.03%
=
0.82
×
0.88
×
29.16%
Sep 30, 2023
21.60%
=
0.81
×
0.89
×
30.16%
Jun 30, 2023
20.18%
=
0.74
×
0.89
×
30.56%
Mar 31, 2023
20.87%
=
0.76
×
0.89
×
30.79%
Dec 31, 2022
17.02%
=
0.79
×
0.86
×
25.11%
Sep 30, 2022
12.44%
=
0.73
×
0.83
×
20.57%
Jun 30, 2022
15.22%
=
0.74
×
0.85
×
24.07%
Mar 31, 2022
16.60%
=
0.77
×
0.86
×
25.25%
Dec 31, 2021
23.05%
=
0.75
×
0.89
×
34.45%
Sep 30, 2021
27.21%
=
0.79
×
0.90
×
38.22%
Jun 30, 2021
19.62%
=
0.77
×
0.87
×
29.50%
Mar 31, 2021
1.19%
=
0.15
×
0.66
×
11.73%
Dec 31, 2020
0.51%
=
0.07
×
0.63
×
11.03%
Sep 30, 2020
5.56%
=
0.71
×
0.65
×
12.05%
Jun 30, 2020
-1.18%
=
—
×
-1.24
×
1.99%
Mar 31, 2020
22.17%
=
1.02
×
0.83
×
26.01%
Dec 31, 2019
24.35%
=
1.04
×
0.84
×
27.93%
Sep 30, 2019
—
=
—
×
—
×
—
Jun 30, 2019
—
=
—
×
—
×
—
Mar 31, 2019
—
=
—
×
—
×
—
Based on:
10-Q (reporting date: 2024-06-30) ,
10-Q (reporting date: 2024-03-31) ,
10-K (reporting date: 2023-12-31) ,
10-Q (reporting date: 2023-09-30) ,
10-Q (reporting date: 2023-06-30) ,
10-Q (reporting date: 2023-03-31) ,
10-K (reporting date: 2022-12-31) ,
10-Q (reporting date: 2022-09-30) ,
10-Q (reporting date: 2022-06-30) ,
10-Q (reporting date: 2022-03-31) ,
10-K (reporting date: 2021-12-31) ,
10-Q (reporting date: 2021-09-30) ,
10-Q (reporting date: 2021-06-30) ,
10-Q (reporting date: 2021-03-31) ,
10-K (reporting date: 2020-12-31) ,
10-Q (reporting date: 2020-09-30) ,
10-Q (reporting date: 2020-06-30) ,
10-Q (reporting date: 2020-03-31) ,
10-K (reporting date: 2019-12-31) ,
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) .
The primary reason for the increase in net profit margin ratio over Q2 2024 is the increase in effect of taxes measured by tax burden ratio.